Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1989-01-23
1993-04-13
Kepplinger, Esther L.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 76, 435 792, 435 17, 4351722, 436534, 436528, 436531, 436538, 436547, 436548, 53038826, 5303911, G01N 33573, A61K 39395
Patent
active
052022340
ABSTRACT:
Methods and reagents for determining the lapse of time since an acute disease event, such as the occurrence of a myocardial infarction, are presented. A serum sample is assayed to determine the concentration of two analyte sets. From these measurements, the time of the acute event can be more accurately determined. Novel antibodies, labeled and insolubilized derivatives of these antibodies, labeled proteins, and kits containing one or more of these reagents are also described.
REFERENCES:
patent: 4067775 (1978-01-01), Wurzbury et al.
patent: 4205057 (1980-05-01), Whitaker
patent: 4722903 (1988-02-01), Kudryk et al.
patent: 4900662 (1990-02-01), Shah et al.
patent: 5047354 (1991-09-01), Foegh et al.
Chemical Abstract 107(5):35341 "Analysis of Creatine Kinase Isoenzymes and Isoforms . . . After Acute Myocardial Infarction".
Chemical Abstract 103(13)102845 "Early Detection of Myocardial Infarction by Analysis of Plasma MM Creatine Kinase Isoforms".
Chemical Abstract 102(3)22264 "Creatine Kinase MM Isoenzyme Sulforms in Myocardium . . . ".
Midline Abstract 75189008 "Immunofluorescent Localization of . . . Malate Dehydrogenase Isozyme in . . . Heart of the Rabbit".
Morison et al., "Effect of Creatine Kinase-MM Subtype Composition on a CK-MB Immunoinhibition Assay", Clin. Chem. 34(3)535-538 (1988).
Suzuke et al., "Monoclonal Antibody Inhibiting Creatine Kinase MM.sub.3 but not Isoform MM.sub.1 ", Clin. Chem. 36(1)153-156 (1990).
Analytical Biochemistry, (1985), 149, pp. 209-217, "Sensitive Quantification of Isoforms of Canine MM Creatine Kinase with an Immunoblot . . . ", Grace et al.
Circulation, (1986), 74, pp. 105-109, "Diagnostic Changes in Plasma Creatine Kinase Isoforms Early After the Onset of Myocardial Infarction", Jaffe et al.
Biochimica Et Biophysica Acta, (1984), 790, pp. 230-237, "Purification of Five Creatine Kinase-MM Variants from Human Heart and Skeletal Muscle", Vaidya et al.
Clinical Chemistry, (1987), 33, pp. 986-987, "Monoclonal Antibodies Specific for the CK-M Subunit and the CKMM Dimer", Daiss.
Clinical Chemistry, (1988), 34, p. 1279, "A Monoclonal Antibody Inhibiting Creatine Kinase-MM3, but not MM1 Sub-Type", Suzuki et al.
Clinical Chemistry, (1989), 35, pp. 493-494, "Two Commercial Test Kits for CK-MM Isoforms Evaluated for Early Recognition of Acute Myocardial . . . "]Shah et al.
Anchin Gerald M.
Shah Vipin D.
Yen Shing-Erh
Internationl Immunoassay Laboratories, Inc.
Kepplinger Esther L.
Spiegel Carol A.
LandOfFree
Myocardial infarction immunoassay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Myocardial infarction immunoassay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Myocardial infarction immunoassay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1154742